Beverly M. Emerson
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Research Subjects
Beverly M. Emerson has a total of 9 co-authors. Here are the top co-authors by number of shared publications:
- Bettina J. Lehman
Affiliation Regulatory Biology Laboratory, Salk Institute for Biological Studies, La Jolla, California, United States of America
1 shared publication - Danielle S.K. Brasino
Cancer Early Detection Advanced Research Center, Knight Cancer Institute Oregon Health and Science University Portland OR 97201 USA
1 shared publication - Fernando J. Lopez-Diaz
Affiliation Regulatory Biology Laboratory, Salk Institute for Biological Studies, La Jolla, California, United States of America
1 shared publication Kenneth E. Diffenderfer
Affiliation Stem Cell Core, Salk Institute for Biological Studies, La Jolla, California, United States of America
1 shared publication- Linjing Fang
Waitt Advanced Biophotonics Core, Salk Institute for Biological Studies
1 shared publication - Maxim Nikolaievich Shokhirev
Razavi Newman Integrative Genomics and Bioinformatics Core, The Salk Institute for Biological Studies
1 shared publication
Latest Publications
- Open Access
- 15 June 2022
- Published by American Association for Cancer Research (AACR) in Cancer Research
- Vol. 82 (12_Supplem) , 196
Abstract 196: Leveraging linked gut microbiome and breast cancer microfluidic chips to study the role of the estrobolome in cancer progression
Gut microbiota are recognized as an integral part in maintaining health, with disturbances in composition linked to disease states ranging from cancer to depression. Breast cancer patient microbiome analysis has demonstrated a correlation between dysbiosis and disease with proposed mechanisms including immune cell regulation, enhanced inflammatory signaling, and modulation of estrogen metabolism through the estrobolome. Current models lack the ability to study communication in one direction or to modulate single variables such as bacterial species or xenobiotic additions without the use of mouse models which suffer from poor translation and assessment opportunities. We have developed two microfluidic chips, one to model the gut microbiome using oxygen impermeable plastic for maintenance of anaerobic bacteria and another to culture breast cancer spheroids under constant flow. Current work has demonstrated viability and polarity maintenance in chip-cultured spheroids and initial development of polarized villus-like gut epithelium. Using these two chips, we will study the impact of breast cancer associated bacteria capable of estrogen metabolism on breast cancer tumorigenic potential. Citation Format: Danielle S. Brasino, Sean D. Speese, Beverly M. Emerson. Leveraging linked gut microbiome and breast cancer microfluidic chips to study the role of the estrobolome in cancer progression [abstract]. In: Proceedings of the American Association for Cancer Research Annual Meeting 2022; 2022 Apr 8-13. Philadelphia (PA): AACR; Cancer Res 2022;82(12_Suppl):Abstract nr 196.
- 15 June 2022
- Published by American Association for Cancer Research (AACR) in Cancer Research
- Vol. 82 (12_Supplem) , 196
Open AccessAbstract 196: Leveraging linked gut microbiome and breast cancer microfluidic chips to study the role of the estrobolome in cancer progression
Gut microbiota are recognized as an integral part in maintaining health, with disturbances in composition linked to disease states ranging from cancer to depression. Breast cancer patient microbiome analysis has demonstrated a correlation between dysbiosis and disease with proposed mechanisms including immune cell regulation, enhanced inflammatory signaling, and modulation of estrogen metabolism through the estrobolome. Current models lack the ability to study communication in one direction or to modulate single variables such as bacterial species or xenobiotic additions without the use of mouse models which suffer from poor translation and assessment opportunities. We have developed two microfluidic chips, one to model the gut microbiome using oxygen impermeable plastic for maintenance of anaerobic bacteria and another to culture breast cancer spheroids under constant flow. Current work has demonstrated viability and polarity maintenance in chip-cultured spheroids and initial development of polarized villus-like gut epithelium. Using these two chips, we will study the impact of breast cancer associated bacteria capable of estrogen metabolism on breast cancer tumorigenic potential. Citation Format: Danielle S. Brasino, Sean D. Speese, Beverly M. Emerson. Leveraging linked gut microbiome and breast cancer microfluidic chips to study the role of the estrobolome in cancer progression [abstract]. In: Proceedings of the American Association for Cancer Research Annual Meeting 2022; 2022 Apr 8-13. Philadelphia (PA): AACR; Cancer Res 2022;82(12_Suppl):Abstract nr 196.
- Open Access
- 7 January 2021
- Published by Public Library of Science (PLoS) in PLOS Genetics
- Vol. 17 (1) , e1009277
Dynamic regulation of CTCF stability and sub-nuclear localization in response to stress
The nuclear protein CCCTC-binding factor (CTCF) has diverse roles in chromatin architecture and gene regulation. Functionally, CTCF associates with thousands of genomic sites and interacts with proteins, such as cohesin, or non-coding RNAs to facilitate specific transcriptional programming. In this study, we examined CTCF during the cellular stress response in human primary cells using immune-blotting, quantitative real time-PCR, chromatin immunoprecipitation-sequence (ChIP-seq) analysis, mass spectrometry, RNA immunoprecipitation-sequence analysis (RIP-seq), and Airyscan confocal microscopy. Unexpectedly, we found that CTCF is exquisitely sensitive to diverse forms of stress in normal patient-derived human mammary epithelial cells (HMECs). In HMECs, a subset of CTCF protein forms complexes that localize to Serine/arginine-rich splicing factor (SC-35)-containing nuclear speckles. Upon stress, this species of CTCF protein is rapidly downregulated by changes in protein stability, resulting in loss of CTCF from SC-35 nuclear speckles and changes in CTCF-RNA interactions. Our ChIP-seq analysis indicated that CTCF binding to genomic DNA is largely unchanged. Restoration of the stress-sensitive pool of CTCF protein abundance and re-localization to nuclear speckles can be achieved by inhibition of proteasome-mediated degradation. Surprisingly, we observed the same characteristics of the stress response during neuronal differentiation of human pluripotent stem cells (hPSCs). CTCF forms stress-sensitive complexes that localize to SC-35 nuclear speckles during a specific stage of neuronal commitment/development but not in differentiated neurons. We speculate that these particular CTCF complexes serve a role in RNA processing that may be intimately linked with specific genes in the vicinity of nuclear speckles, potentially to maintain cells in a certain differentiation state, that is dynamically regulated by environmental signals. The stress-regulated activity of CTCF is uncoupled in persistently stressed, epigenetically re-programmed “variant” HMECs and certain cancer cell lines. These results reveal new insights into CTCF function in cell differentiation and the stress-response with implications for oxidative damage-induced cancer initiation and neuro-degenerative diseases.
- 7 January 2021
- Published by Public Library of Science (PLoS) in PLOS Genetics
- Vol. 17 (1) , e1009277
Open AccessDynamic regulation of CTCF stability and sub-nuclear localization in response to stress
The nuclear protein CCCTC-binding factor (CTCF) has diverse roles in chromatin architecture and gene regulation. Functionally, CTCF associates with thousands of genomic sites and interacts with proteins, such as cohesin, or non-coding RNAs to facilitate specific transcriptional programming. In this study, we examined CTCF during the cellular stress response in human primary cells using immune-blotting, quantitative real time-PCR, chromatin immunoprecipitation-sequence (ChIP-seq) analysis, mass spectrometry, RNA immunoprecipitation-sequence analysis (RIP-seq), and Airyscan confocal microscopy. Unexpectedly, we found that CTCF is exquisitely sensitive to diverse forms of stress in normal patient-derived human mammary epithelial cells (HMECs). In HMECs, a subset of CTCF protein forms complexes that localize to Serine/arginine-rich splicing factor (SC-35)-containing nuclear speckles. Upon stress, this species of CTCF protein is rapidly downregulated by changes in protein stability, resulting in loss of CTCF from SC-35 nuclear speckles and changes in CTCF-RNA interactions. Our ChIP-seq analysis indicated that CTCF binding to genomic DNA is largely unchanged. Restoration of the stress-sensitive pool of CTCF protein abundance and re-localization to nuclear speckles can be achieved by inhibition of proteasome-mediated degradation. Surprisingly, we observed the same characteristics of the stress response during neuronal differentiation of human pluripotent stem cells (hPSCs). CTCF forms stress-sensitive complexes that localize to SC-35 nuclear speckles during a specific stage of neuronal commitment/development but not in differentiated neurons. We speculate that these particular CTCF complexes serve a role in RNA processing that may be intimately linked with specific genes in the vicinity of nuclear speckles, potentially to maintain cells in a certain differentiation state, that is dynamically regulated by environmental signals. The stress-regulated activity of CTCF is uncoupled in persistently stressed, epigenetically re-programmed “variant” HMECs and certain cancer cell lines. These results reveal new insights into CTCF function in cell differentiation and the stress-response with implications for oxidative damage-induced cancer initiation and neuro-degenerative diseases.